Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood

Expert Opinion on Biological Therapy

Volumn 12, Issue SUPPL. 1, 2012, Pages

  Butt, A ^a   Ahmad, M S ^a   Powrie, J ^a   Swaminathan, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Blindness; Diabetic retinopathy; Phosphodiesterase 6C; Retina specific mRNA; Retinal amine oxidase; Rhodopsin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BETA ACTIN; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 6C; RETINAL AMINE OXIDASE; RHODOPSIN; UNCLASSIFIED DRUG;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RNA, MESSENGER;

EID: 84861420329     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.688947     Document Type: Conference Paper

References (25)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for 2000 and projections for 2030. Diabetes Care 2004;27:1047-53 (Pubitemid 38579764)
2. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study: II prevalence and risk of diabetic retinopathy when age at diagnosis is less than thirty years. Arch Ophthalmol 1984;102:520-6 (Pubitemid 14127838)
3. Harding S, Greenwood R, Aldington S, et al. Diabetic retinopathy grading and disease management working party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-71 (Pubitemid 41701477)
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
5. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995;102:647-61
6. Klein R, Sharrett AR, Klein BE, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology 2002;109:1225-34 (Pubitemid 34700911)
7. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374-85 (Pubitemid 30609364)
8. Harding S, Garvican L, Talbot J. The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning. Eye (Lond) 2005;19:1009-11 (Pubitemid 43114983)
9. Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003;103:149-52 (Pubitemid 35461505)
10. Lo YMD, Chiu RWK. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-7
11. Lo YMD, Tein MS, Pang CC, et al. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-30 (Pubitemid 28195915)
12. Lo YMD, Rainer TH, Chan LYS, et al. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-23 (Pubitemid 30152256)
13. Wijeratne S, Butt A, Burns S, et al. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann NY Acad Sci 2004;1022:232-8 (Pubitemid 38951608)
14. Grammatopoulos D, Elliott Y, Smith SC, et al. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 2003;56:162-6 (Pubitemid 36724228)
15. Fung EC, Butt A, Carr-White G, et al. Circulating microRNAs in the assessment of heart failure and microRNa-133A as a potential biomarker of cardiac remodeling. J Nucl Acid Res 2011;2(1S):35
16. 16: Agalou S, Butt AN, Chowienczyk P, et al. Hypertension and circulating mRNA for 11beta-hydroxysteroid dehydrogenase type II. Ann NY Acad Sci 2008;1137:290-5
17. Hamaoui K, Butt A, Powrie J, Swaminathan R. Concentration of circulating rhodopsin mRNA in diabetic retinopathy. Clin Chem 2004;50:2152-5 (Pubitemid 39425856)
18. Shalchi Z, Sandhu HS, Butt AN, et al. Retina-specific mRNA in the assessment of diabetic retinopathy. Ann NY Acad Sci 2008;1137:253-7
19. Ganong WF. Review of Medical Physiology. The McGraw-Hill Companies; Singapore: 2005. p. 157-9
20. Imamura Y, Kubota R, Wang Y, et al. Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping. Genomics 1997;40:277-83 (Pubitemid 27124090)
21. Rainer TH, Wong LK, Lam W, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003;49:562-9 (Pubitemid 36379520)
22. Holford NC, Sandhu HS, Thakkar H, et al. Stability of beta-actin mRNA in plasma. Ann NY Acad Sci 2008;1137:108-11
23. Chelly J, Concordet JP, Kaplan JC, et al. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989;86:2617-21 (Pubitemid 19112598)
24. Holford NC, Ramoutar A, Butt AN, et al. Normalization of circulating nucleic acid results. Ann NY Acad Sci 2008;1137:112-18
25. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93